PUBLIC SUMMARY DOCUMENT Product: Abiraterone, tablet, 250 mg (as acetate), Zytiga® Sponsor: Janssen-Cilag Pty Ltd Date of PBAC Consideration: November[removed]Purpose of Application

First Page		Document Content
Date: 2014-10-01 21:56:22 Benzoates Carbamates Oncology Abiraterone Antiandrogens Pyridines Docetaxel Prostate cancer Febrile neutropenia Medicine Biology Chemistry		PUBLIC SUMMARY DOCUMENT Product: Abiraterone, tablet, 250 mg (as acetate), Zytiga® Sponsor: Janssen-Cilag Pty Ltd Date of PBAC Consideration: November[removed]Purpose of Application Add to Reading List Source URL: www.pbs.gov.au Download Document from Source Website File Size: 38,05 KB Share Document on Facebook

	CMTF005 - Food is Medicine - Checklist_Debranded DocID: 1xVMk - View Document
	Pacemakers and Implantable Cardiac Defibrillators: Software Radio Attacks and Zero-Power Defenses Daniel Halperin† Thomas S. Heydt-Benjamin† DocID: 1xVge - View Document
	CMTF005 - Food is Medicine - Checklist_Debranded_with bleed DocID: 1xUza - View Document
	CMTF005 - Food is Medicine - Checklist_Debranded_edited DocID: 1xTtU - View Document
	PDF Document DocID: 1xSqy - View Document